Together, these findings uncover a novel WISP-3/MEK-ERK/miR-6894-5p/CCL4 axis that contributes to monocyte recruitment and inflammation in RA, providing new insight into the post-transcriptional mechanisms underlying RA pathogenesis and potential targets for therapeutic intervention. Here, MAP2K7 is linked to rheumatoid arthritis.